1. Home
  2. TRDA vs AHRT Comparison

TRDA vs AHRT Comparison

Compare TRDA & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$12.65

Market Cap

500.4M

Sector

Health Care

ML Signal

HOLD

AHRT

AH Realty Trust Inc. Common Stock

N/A

Current Price

$6.09

Market Cap

455.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
AHRT
Founded
2016
1979
Country
United States
United States
Employees
N/A
98
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
500.4M
455.6M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
TRDA
AHRT
Price
$12.65
$6.09
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$21.00
$7.00
AVG Volume (30 Days)
144.6K
758.2K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
9.27%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
$854.92
Revenue Next Year
$50.80
$11.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$5.13
52 Week High
$14.49
$6.18

Technical Indicators

Market Signals
Indicator
TRDA
AHRT
Relative Strength Index (RSI) 46.56 60.43
Support Level $10.84 $5.52
Resistance Level $12.93 $6.14
Average True Range (ATR) 0.58 0.13
MACD -0.19 0.04
Stochastic Oscillator 23.92 87.50

Price Performance

Historical Comparison
TRDA
AHRT

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About AHRT AH Realty Trust Inc. Common Stock

AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.

Share on Social Networks: